Systemic corticosteroids in nonarteritic ischemic optic neuropathy

Nonarteritic ischemic optic neuropathy (NAION) is one of the most prevalent optic nerve disorders seen in ophthalmic practice. The role of corticosteroid therapy in NAION remains a highly controversial area of debate in ophthalmology. This brief review will provide an overview of the current clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Zubidi, Nagham, Zhang, Jason, Spitze, Arielle, Lee, Andrew G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Ophthalmology Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278114/
https://www.ncbi.nlm.nih.gov/pubmed/25449939
http://dx.doi.org/10.4103/0301-4738.146015
_version_ 1782350472161525760
author Al-Zubidi, Nagham
Zhang, Jason
Spitze, Arielle
Lee, Andrew G
author_facet Al-Zubidi, Nagham
Zhang, Jason
Spitze, Arielle
Lee, Andrew G
author_sort Al-Zubidi, Nagham
collection PubMed
description Nonarteritic ischemic optic neuropathy (NAION) is one of the most prevalent optic nerve disorders seen in ophthalmic practice. The role of corticosteroid therapy in NAION remains a highly controversial area of debate in ophthalmology. This brief review will provide an overview of the current clinical evidence on this topic as well as some comment on the medical debate.
format Online
Article
Text
id pubmed-4278114
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42781142015-01-02 Systemic corticosteroids in nonarteritic ischemic optic neuropathy Al-Zubidi, Nagham Zhang, Jason Spitze, Arielle Lee, Andrew G Indian J Ophthalmol Ophthalmology Practice Nonarteritic ischemic optic neuropathy (NAION) is one of the most prevalent optic nerve disorders seen in ophthalmic practice. The role of corticosteroid therapy in NAION remains a highly controversial area of debate in ophthalmology. This brief review will provide an overview of the current clinical evidence on this topic as well as some comment on the medical debate. Medknow Publications & Media Pvt Ltd 2014-10 /pmc/articles/PMC4278114/ /pubmed/25449939 http://dx.doi.org/10.4103/0301-4738.146015 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Ophthalmology Practice
Al-Zubidi, Nagham
Zhang, Jason
Spitze, Arielle
Lee, Andrew G
Systemic corticosteroids in nonarteritic ischemic optic neuropathy
title Systemic corticosteroids in nonarteritic ischemic optic neuropathy
title_full Systemic corticosteroids in nonarteritic ischemic optic neuropathy
title_fullStr Systemic corticosteroids in nonarteritic ischemic optic neuropathy
title_full_unstemmed Systemic corticosteroids in nonarteritic ischemic optic neuropathy
title_short Systemic corticosteroids in nonarteritic ischemic optic neuropathy
title_sort systemic corticosteroids in nonarteritic ischemic optic neuropathy
topic Ophthalmology Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278114/
https://www.ncbi.nlm.nih.gov/pubmed/25449939
http://dx.doi.org/10.4103/0301-4738.146015
work_keys_str_mv AT alzubidinagham systemiccorticosteroidsinnonarteriticischemicopticneuropathy
AT zhangjason systemiccorticosteroidsinnonarteriticischemicopticneuropathy
AT spitzearielle systemiccorticosteroidsinnonarteriticischemicopticneuropathy
AT leeandrewg systemiccorticosteroidsinnonarteriticischemicopticneuropathy

Ejemplares similares